Krebs Biochemicals & Industries Ltd-$
Results for the quarter ended 30602026
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 06 Aug 2026, 01:50 PM IST · BSE ID: 5c9ce52f-d7cd-40ba-978d-3bab12d89435
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has officially approved the financial numbers for the first three months of its current business year.
🤖 AI Summary
- Krebs Biochemicals & Industries Ltd (KBIL) approved its unaudited financial results for the quarter ended June 30, 2026.
- The Board of Directors took on record the Limited Review Report from auditors for the first quarter.
- The Board meeting, held on August 6, 2026, started at 11:30 am and concluded at 01:30 p.m.
- The company informed BSE and NSE as per Regulation 30 and 33 of SEBI (LODR) Regulations 2015.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are informed that the company has completed the regulatory step of approving its first quarter financial results for FY27.
🔍
Management Signal
The Board's approval of the unaudited financial results indicates adherence to regulatory timelines for financial reporting.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Release of the detailed unaudited financial results for Q1 FY27.
Any subsequent press releases or investor calls regarding Q1 FY27 performance.
Board meeting outcomes for Q2 FY27 results in the coming months.
LOW RISK
The filing is a routine compliance update without new business or financial risks disclosed.
💡 Investor Takeaway
Krebs Biochemicals & Industries Ltd's Board of Directors approved the unaudited financial results for the quarter ended June 30, 2026, and also took on record the Limited Review Report by the auditors. This filing confirms completion of a compliance requirement.
❓ Frequently Asked Questions
What event did Krebs Biochemicals & Industries Ltd announce on August 6, 2026?
Krebs Biochemicals & Industries Ltd announced the outcome of its Board Meeting, where the unaudited financial results for the 1st quarter ended June 30, 2026, were approved.
What was the duration of the Board Meeting for Krebs Biochemicals & Industries Ltd?
The Board Meeting of Krebs Biochemicals & Industries Ltd commenced at 11:30 am and concluded at 01:30 p.m. on August 6, 2026.
What regulatory compliance did Krebs Biochemicals & Industries Ltd fulfill with this filing?
Krebs Biochemicals & Industries Ltd fulfilled compliance under Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.
Questions based on this BSE filing only. For information purposes.